Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-27 | Dr. Farfel’s pharmaceutical industry experience relating to executive management, strategic planning, medical and scientific expertise and pharmaceutical industry experience as it relates to drug development and regulatory affairs are among the qualifications she brings to the Board. |
| 2021-04-23 | Dr. Farfel holds a Ph.D. in Neuropsychopharmacology from the University of Chicago and has extensive pharmaceutical industry experience. |
| 2022-04-25 | Dr. Farfel holds a Ph.D. in Neuropsychopharmacology from the University of Chicago and a bachelor’s degree in Biochemistry from the University of Virginia. |
| 2023-04-27 | Dr. Farfel holds a Ph.D. in Neuropsychopharmacology from the University of Chicago, where she is a Director on the Alumni Board. Dr. Farfel also holds a bachelor’s degree in Biochemistry from the University of Virginia. |
| 2024-08-12 | Dr. Farfel holds a Ph.D. in Neuropsychopharmacology from the University of Chicago. Dr. Farfel also holds a bachelor’s degree in Biochemistry from the University of Virginia. |
Data sourced from SEC filings. Last updated: 2026-02-03